本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

14.93
+0.40002.75%
盘后15.240.3100+2.08%19:52 EDT
成交量:95.74万
成交额:1,419.51万
市值:9.08亿
市盈率:-8.14
高:15.08
开:14.54
低:14.36
收:14.53
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:4,168.06万
量比:1.03
换手率:2.30%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.48%
总资产收益率:-9.55%
市净率:0.95
市盈率(LYR):-8.14

数据加载中...

2025/05/08

重要事件披露

Form 8-K - Current report
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/05

重要事件披露

Form 8-K - Current report
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]